CCI clears Sun-Ranbaxy merger deal with riders; asks two companies to divest some products – The Economic Times

The long-pending $4-billion merger between Sun Pharma and Ranbaxy today got a conditional approval from fair trade watchdog CCI, which asked the two companies to divest some key products along with other changes to the deal to address the anti-competitive issues.

The fair trade regulator’s approval comes after the first ever public scrutiny carried out by it for a merger, which was announced in April and would create India’s largest and world’s fifth biggest drug-maker.

Read more – The Economic Times